Randomized controlled trials in *Obesity* and *Diabetes Care* show that patients achieving 1015% weight loss over 1218 months maintain that loss long-term, while those losing weight rapidly often regain it
This wondrous peptide also stimulates specific growth hormone receptors and gene expressions
Mechanisms of action: two distinct cascades BPC-157: NO pathway modulation and growth factor expression Preclinical studies have suggested that BPC-157 acts primarily through three axes: NO (nitric oxide) pathway : BPC-157 modulates endothelial NO signaling, favoring local vasodilation and perfusion of injured tissues VEGF-R2 expression and angiogenesis : animal models have shown increased formation of new capillaries at the injury site Interactions with dopaminergic, serotonergic and GABAergic pathways : BPC-157 exhibits a pleiotropic profile influencing neurological and digestive healing Documented strengths (animal models): healing of tendons, ligaments, gastrointestinal mucosa, bone, teeth, vessels, cornea
The product is distributed Australian-domestic from Sydney, NSW, for in vitro and laboratory research applications
Many of the large direct-to-consumer companies selling them, like Ro Health and Hims, are household names, publicly traded on the New York Stock Exchange and servicing thousands of patient-consumers, providing prescriptions to treat conditions like depression, smoking cessation, and hair loss
